Clinical trial
Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
NCT00133757 · Centre for Addiction and Mental Health, Other · Completed
Key facts
| NCT number | NCT00133757 |
|---|---|
| Title | Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers |
| Official title | Pharmacotherapy-assisted Extinction (Pharmacoextinction): A Novel Approach to the Treatment of Nicotine Dependence in Humans |
| Lead sponsor | Centre for Addiction and Mental Health, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nicotine Dependence, Tobacco Dependence |
| Intervention type | Drug |
| Interventions | Bupropion SR |
| Enrollment | 50 |
| Start date | Jun 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Feb 15, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: